Spec, Therapy Development at Vontive

Deerfield, Illinois, United States

Vontive Logo
Not SpecifiedCompensation
Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, Medical Devices, Kidney Care, DialysisIndustries

Requirements

  • Preferred RN, BSN with at least 3 years’ experience in critical care medicine (ICU/ED). Candidates without a nursing degree but with 8+ years of medical device, training and experience will also be considered
  • 2 or more years sales experience required preferably in the medical device industry, and/or a minimum of 2 years of experience delivering CRRT in the hospital ICU setting
  • Prior experience selling to Capital Equipment markets, and “Conceptual Selling” to physicians and hospitals in critical care settings is highly desirable
  • Critical Care or Dialysis Nursing background preferred
  • Strong, demonstrated expertise in product and therapy knowledge
  • Demonstrated ability to take a positive, proactive approach to solving complex and/or unusual clinical or technical problems
  • Good interpersonal, communicative and oral skills required
  • Demonstrated ability to start new therapy programs
  • Proven expertise in product and therapy knowledge
  • Demonstrated ability and desire to teach; demonstrated self-confidence and effectiveness in dealing with a wide variety of student types
  • Demonstrated ability to collaborate on pricing, contracts and renewals
  • Demonstrated ability to work in a team environment and matrixed organization
  • Proficiency with MS Office software

Responsibilities

  • Manage and grow CRRT therapy in existing contracted accounts - Focus on high growth potential accounts within territory
  • Collaborate with the Territory Business Manager (TBM) to develop strategic goals to drive therapy utilization and territory growth
  • Establish and develop consultative role with key stakeholders to promote therapy development, facilitate relationship building and provide necessary customer service within existing customer base
  • Solicit, develop and maintain successful relationships with key healthcare professionals in assigned accounts
  • Educate and train critical care staff within new and existing accounts to product portfolio and CRRT therapy
  • Consistently search for all growth & expansion opportunities within the existing customer base
  • Act as lead for incremental machine sales and key CRRT product penetration
  • Enhance therapy utilization and drive Vantive value in the critical care space
  • Assist Clinical Educator – CRRT with logistics and trainings at customer locations
  • Assists in contract negotiations with the TBM

Skills

Key technologies and capabilities for this role

CRRTContinuous Renal Replacement TherapyMulti-Organ Extracorporeal SupportNephrologyPulmonaryCritical CareAccount ManagementSalesClinical SupportTherapy UtilizationStakeholder Engagement

Questions & Answers

Common questions about this position

What qualifications are required for the Spec, Therapy Development role?

Preferred qualifications include RN, BSN with at least 3 years’ experience in critical care medicine (ICU/ED), or candidates without a nursing degree but with 8+ years of medical device, training and experience. Additionally, 2 or more years of sales experience is required.

What is the employment type for this position?

This is a full-time position.

What does the company culture at Vantive emphasize?

Vantive fosters a community of focused, courageous people who don’t settle for the mediocre and are driven to improve patients’ lives worldwide through innovations in vital organ therapies.

What are the main responsibilities in this role?

Responsibilities include managing and growing CRRT therapy in existing accounts, collaborating with the Territory Business Manager, educating and training critical care staff, and assisting in contract negotiations.

What makes a strong candidate for this position?

Strong candidates have critical care experience (ICU/ED), sales background, and the ability to build relationships with healthcare professionals while driving therapy utilization and business growth.

Vontive

Provides investment property mortgage solutions

About Vontive

Vontive provides investment property mortgages using technology to simplify and speed up the loan process. Their main product is a "bolt-on" technology that allows retail brands to easily launch their own mortgage services without needing programming skills. This no-code solution can be set up in just a few weeks, making it quicker for brands to offer mortgages. Vontive stands out from competitors by acting as a bridge between real estate investors, lenders, and capital providers, charging fees for their services that reduce traditional risks and inefficiencies in real estate financing. The company's goal is to modernize the investment real estate market by making the mortgage process more efficient and transparent for both retail brands and financial institutions.

San Francisco, CaliforniaHeadquarters
2017Year Founded
$32.1MTotal Funding
DEBTCompany Stage
Financial Services, Real EstateIndustries
11-50Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
Unlimited Paid Time Off
Parental Leave
Short- and Long-term Disability Coverage
Life Insurance
Wellness Program

Risks

Increased competition from fintech companies could erode Vontive's market share.
Potential regulatory scrutiny may lead to higher compliance costs and challenges.
Economic downturns could impact demand for investment property mortgages.

Differentiation

Vontive offers a no-code, white-label mortgage solution for real estate investors.
The platform integrates financial institutions through a unique debt marketplace.
Founded by industry veterans, Vontive leverages decades of mortgage and financial expertise.

Upsides

Vontive ranked #10 on the 2022 Deloitte Technology Fast 500 with 9,154% growth.
The company has financed over $1.1 billion in residential properties since April 2022.
Vontive's B2C ecosystem reaches over 1.5 million real estate investors.

Land your dream remote job 3x faster with AI